Business Daily Media

Business Marketing

.

Eisai's Discovery Research on Multikinase Inhibitor Lenvatinib Honored with PSJ Award for Drug Research and Development '20

  • Written by ACN Newswire - Press Releases

image

TOKYO, Mar 25, 2020 - (JCN Newswire) - Eisai Co., Ltd. has announced that drug discovery research conducted on lenvatinib mesylate (brand name: LENVIMA, lenvatinib), the orally available multikinase inhibitor discovered by Eisai, has been honored with The Pharmaceutical Society of Japan (PSJ) Award for Drug Research and Development '20 by the PSJ.

Read more //?#

Popular

Christmas Cash Flow Crush For Australian Businesses

Australian businesses are being warned to prepare for cash flow challenges this Christmas with an increase in unpaid invoices, rising inflation and staffing shortages.  Internal data from funding solutions provider OptiPay sh...

WithYouWithMe announces Tom Larter as new CEO

Australian global tech SME, WithYouWithMe (WYWM), has announced the appointment of its new CEO, Tom Larter, to replace founding CEO Tom Moore who is stepping back from daily operations after seven years at the helm. WYWM is a s...

Security Alarm Code Basics

Many of us pay more attention to protecting our mobile phone passwords than we do to protecting our security alarm codes, but if you take a moment to really think about it, what’s more important? Keeping prying eyes away from ...